Susan Hasty, Publisher
Table of Contents . . . May 31st, 2005
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Drug Law Weekly | Other Publications
Arena Pharmaceuticals, Inc. - European patent issued for 5-HT2C receptor modulators
Ark Therapeutics Group plc - International patents granted for Vitor
BioMarin Pharmaceutical, Inc. - Rights acquired to 6R-BH4 for treating vascular dysfunction
Cephalon, Inc. - Company provides update on patent litigation matters
Children's Hospital of Philadelphia - Is the vaccine industry ailing?
Consumers Union - Law must ensure drug ads accurately inform of risks
Dermisonics, Inc. - Patent office issues notice of allowance for transdermal drug-delivery device
Healthcare Coverage - Highmark enables individuals to take advantage of health savings accounts
InforMedix Holdings, Inc. - Device improves patient medication adherence in schizophrenia trial
Matrixx Initiatives, Inc. - OTC pharma company announces first quarter 2005 financial results
Osteoporosis - Experts: Osteoporosis not a healthcare priority for patients or physicians
Osteoporosis - Group says bone loss is not a healthcare priority for patients or physicians
Perrigo Company - Pharma company reports net loss of $5.15 per share
Phylogica Ltd - Drug discovery company secures patent for gene fragment libraries
Seattle Genetics, Inc. - U.S. patent relating to antibody-drug conjugate technology granted
AMS Health Sciences, Inc. - Nutritional supplements company reports loss of $0.19 per share
Acuity Pharmaceuticals - Ophthalmic pharmaceutical firm forms scientific advisory board
Adolor Corporation - Alvimopan effective for treatment of opioid-induced bowel dysfunction
Aesthera Corp. - Aesthera Photopneumatic System approved by U.S. FDA
Alfred I. duPont Hospital for Children, Wilmington - Soft-tissue release effective for children with spastic hip subluxation
American Psychiatric Association - Survey shows mental illness stigmas are receding, but misconceptions remain
Ascend Therapeutics - Phase II trial results presented for transdermal 4-hydroxytamoxifen therapy
Aston University, West Midlands - Amino acids make aerosolized gene delivery more robust
AstraZeneca - Data show Cerovive reduces disability in patients with acute ischemic stroke
Avecia - Manufacturing agreement signed for ProMune
Avidia, Inc. - Biopharmaceutical firm raises $28.5M in series B financing
Bausch & Lomb - Two-year data from clinical trial of noninfectious uveitis therapy presented
Baxa Corporation - New PhaSeal system component launched for accessing needleless connectors
Bayhill Therapeutics, Inc. - Drug developer raises $35.4M in series B financing
Baylor College of Medicine - TNF-alpha reduces endothelial cell expression of thrombomodulin and EPCR
Beckman Coulter, Inc. - HemosIL D-Dimer assay cleared to aid diagnosis of DVT, pulmonary embolism
BioDelivery Sciences International, Inc. - NDA submitted to U.S. FDA for Emezine
BioDelivery Sciences International, Inc. - William S. Poole appointed to drug delivery company's board of directors
BioSante Pharmaceuticals, Inc. - CaP manufacturing agreement signed
BioVex, Ltd. - IND submitted to U.S. FDA for trial of malignant melanoma therapy
Boston University - Community efforts can reduce alcohol fatalities
Burrill & Company - Biotech gets a much needed boost in April
CV Therapeutics, Inc. - Pharmaceutical firm reports loss of $1.31 per share
Cadence Pharmaceuticals, Inc. - Pharmaceutical company appoints Kenneth Heilbrunn as senior VP
Cangene - FDA approves Vaccinia immune globulin for some reactions to smallpox vaccine
Caron Foundation - Alcoholism is a major healthcare crisis
Celera Genomics - Genomics company files IND application for HDAC inhibitor, CRA-024781
Center for Disease Control and Prevention - Reports describe recent advances in tuberculosis research
Centocor Inc. - New findings in the area of immunology described
Centre Hospitalier Lyon Sud - Preoperative staging offered high prognostic value in rectal cancer
Chiang Mai University - P-glycoprotein function and expression inhibited by kaempferol and quercetin
Children's Hospital & Reg. Med. Cntr., Seattle - New study compares influenza vaccine schedules in children
Chonnam National University, Kwangju - Brain-specific angiogenesis inhibitor 1 restricts corneal neovascularization
City Hospital of Zurich - Potential risk of secondary cancer induction assessed by organ equivalent dose
Colorado State University, Fort Collins - Refeeding after chronic dietary energy restriction reverses anticancer effect
Compex Technologies - EMS products maker announces FDA clearance of IF 3WAVE interferential device
Cook, Inc. - Trial begins for paclitaxel-eluting stent for PAD
Copernicus Therapeutics, Inc. - Company receives orphan drug designation for cystic fibrosis treatment
Copernicus Therapeutics, Inc. - DNA drug delivery being developed for eye diseases
Cumhuriyet University - Fasting does not increase risk of ceftriaxone-associated pseudolithiasis
Cutting Edge Information - Peer review, impact factor among top criteria for medical publication selection
Deltex Medical Group, plc - Study: CardioQ reduces hospital stay by 2 days in colorectal surgery patients
Diet & Nutrition - Health claim supported for garlic in the prevention of heart disease
Dimock Community Health Center, Boston - Methadone clinics promote access to hepatitis C screening and treatment
Duke University - Morphine for chest pain increases death risk
ELA Medical - FDA grants clearance for technology that reduces unnecessary ventricular pacing
Erasmus Medical Center Sophia - Propofol 6% used successfully as sedative in young children
Exelixis, Inc. - Company files IND application for anticancer compound XL844
Guidant Corporation - Approval granted to begin U.S. drug eluting stent trial
Infectious Diseases - A new study examines how shared pathogens affect host populations
Institute of Medicine - Human resource crisis in HIV/AIDS, IOM says
NIR Diagnostics Inc. - Diagnostics company announces financial and operational results
Oscient Pharmaceuticals Corporation - Pharmaceutical company reports first quarter financial results
Sangamo BioSciences, Inc. - Clinical trial initiated for therapy to regenerate nerve function in diabetics
St. Jude Children's Research Hospital - Lab model overcomes limits on human hematopoietic stem cell studies
Tercica, Inc. - FDA accepts Increlex NDA with priority review for the treatment of short stature
U.S. Food & Drug Administration - Residual dipolar couplings used to detect motion in sucrose
Vasomedical, Inc. - Cardio-focused company restructures to pursue congestive heart failure market
Weizmann Inst. of Science, Israel - Scientists reveal system of embryonic law and order
Yale University - Legionella pneumophila antigens studied, macrophage processing clarified
deCODE genetics - Gene discovery biopharmaceutical company reports Q1 2005 financial results
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.